Senior Director, Market Access Western Europe Region

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical thoughtful use of AI to improve clarity, speed, and quality of work. About BridgeBio Pharma, Inc. BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide. Who We Are BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fuelling the company’s international growth. At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world. To learn more about our story and company culture, visit us at https://bridgebio.com What You'll Do This critical role reporting to the regional General Manager - WEU, requires you to be a driven individual with a track record in navigating in the medico-economic environment, securing reimbursement, pricing patient access to medicines in France (as a priority), Belgium, and the Netherlands. Establish e ffective collaboration and communication with external stakeholders, such as healthcare professionals, payers, policy makers including representing BridgeBio and leading and/ or actively participating in HTA and pricing meetings, and the medico-economic community events is also critical. Your primary role will be to design, anticipate and drive all steps of the HTA, pricing and reimbursement process within each country and to engage with early scientific advice and early access programs where when needed. You will, therefore, be able to operate in a fast-paced, sometimes ambiguous environment where you will influence without authority and effectively communicate WEU market access strategies to all levels. Responsibilities The responsibilities below give the general nature and level of work but are not intended to be an exhaustive list of activities, duties, and responsibilities required. Therefore, you will be expected to perform all other duties as assigned or required. HTA, Pricing Reimbursement Lead internal and external stakeholders to develop and execute a strategy to demonstrate the val ... (truncated, view full listing at source)